OA12174A - Heterocyclic amide derivatives. - Google Patents
Heterocyclic amide derivatives. Download PDFInfo
- Publication number
- OA12174A OA12174A OA1200200235A OA1200200235A OA12174A OA 12174 A OA12174 A OA 12174A OA 1200200235 A OA1200200235 A OA 1200200235A OA 1200200235 A OA1200200235 A OA 1200200235A OA 12174 A OA12174 A OA 12174A
- Authority
- OA
- OAPI
- Prior art keywords
- fluoro
- compound according
- methyl
- alkyl
- amide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18015900P | 2000-02-04 | 2000-02-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA12174A true OA12174A (en) | 2006-05-09 |
Family
ID=22659425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200200235A OA12174A (en) | 2000-02-04 | 2001-01-26 | Heterocyclic amide derivatives. |
Country Status (37)
| Country | Link |
|---|---|
| US (2) | US6548671B2 (es) |
| EP (1) | EP1252154A1 (es) |
| JP (1) | JP2003522164A (es) |
| KR (2) | KR20050009776A (es) |
| CN (1) | CN1398265A (es) |
| AP (1) | AP2002002595A0 (es) |
| AR (1) | AR027349A1 (es) |
| AU (1) | AU2699701A (es) |
| BG (1) | BG106922A (es) |
| BR (1) | BR0108002A (es) |
| CA (1) | CA2399214A1 (es) |
| CZ (1) | CZ20022542A3 (es) |
| EA (2) | EA005320B1 (es) |
| EE (1) | EE200200432A (es) |
| GE (1) | GEP20043301B (es) |
| GT (1) | GT200100021A (es) |
| HK (1) | HK1050006A1 (es) |
| HN (1) | HN2001000021A (es) |
| HR (1) | HRP20020638A2 (es) |
| HU (1) | HUP0204560A3 (es) |
| IL (1) | IL150862A0 (es) |
| IS (1) | IS6468A (es) |
| MA (1) | MA25653A1 (es) |
| NO (1) | NO20023675L (es) |
| NZ (1) | NZ520075A (es) |
| OA (1) | OA12174A (es) |
| PA (1) | PA8511401A1 (es) |
| PE (1) | PE20011057A1 (es) |
| PL (1) | PL357094A1 (es) |
| SK (1) | SK10882002A3 (es) |
| SV (1) | SV2002000302A (es) |
| TN (1) | TNSN01021A1 (es) |
| TW (1) | TW200804311A (es) |
| UA (1) | UA72789C2 (es) |
| UY (1) | UY26568A1 (es) |
| WO (1) | WO2001057023A1 (es) |
| ZA (1) | ZA200206140B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002347985A1 (en) * | 2001-11-15 | 2003-06-10 | Eli Lilly And Company | Peroxisome proliferator activated receptor alpha agonists |
| SE0201980D0 (sv) * | 2002-06-24 | 2002-06-24 | Astrazeneca Ab | Novel compounds |
| US20040087571A1 (en) * | 2002-10-30 | 2004-05-06 | Pfizer Inc | Methods of using CCR1 antagonists as immunomodulatory agents |
| US20040097554A1 (en) * | 2002-10-30 | 2004-05-20 | Pfizer Inc | Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents |
| AU2006315436A1 (en) | 2005-11-15 | 2007-05-24 | Vertex Pharmaceuticals Incorporated | Azaindazoles useful as inhibitors of kinases |
| CN1971279B (zh) * | 2006-12-06 | 2011-05-18 | 华中农业大学 | 喹噁啉-2-羧酸残留的酶联免疫检测方法及试剂盒 |
| PT3609868T (pt) | 2017-03-13 | 2023-12-18 | Raqualia Pharma Inc | Derivados de tetra-hidroquinolina como antagonistas do recetor p2x7 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL88619A0 (en) * | 1987-12-15 | 1989-07-31 | Pfizer | Non-peptidic renin inhibitors |
| EP0374098A3 (de) * | 1988-12-15 | 1991-05-02 | Ciba-Geigy Ag | Retrovirale Proteasehemmer |
| PT100865A (pt) | 1991-09-11 | 1994-01-31 | Smithkline Beckman Corp | Isosteros de peptido contendo um heterociclo, processo de preparacao dos mesmos seus intermediarios, uso e composicoes farmaceuticas |
| EP0628035A4 (en) * | 1992-02-26 | 1995-03-29 | Smithkline Beecham Corp | RETROVIRAL PROTEASE INHIBITORS. |
| PT708085E (pt) * | 1994-10-19 | 2002-11-29 | Novartis Ag | Eteres antivirais de isosteros de substrato de aspartato protease |
| BR9807858A (pt) * | 1997-02-26 | 2000-02-22 | Pfizer | Derivados de amida do ácido heteroaril-hexanóico, suas preparaçÊes e seus usos como inibidores seletios de mip-1.alfa ligando aos seus receptores ccr1 |
| KR100385529B1 (ko) * | 1998-02-05 | 2003-05-27 | 화이자 프로덕츠 인코포레이티드 | 신규 디하이드록시헥산산 유도체 |
-
2001
- 2001-01-26 CN CN01804508A patent/CN1398265A/zh active Pending
- 2001-01-26 EA EA200200749A patent/EA005320B1/ru not_active IP Right Cessation
- 2001-01-26 WO PCT/IB2001/000107 patent/WO2001057023A1/en not_active Application Discontinuation
- 2001-01-26 HU HU0204560A patent/HUP0204560A3/hu unknown
- 2001-01-26 NZ NZ520075A patent/NZ520075A/en unknown
- 2001-01-26 EP EP01901328A patent/EP1252154A1/en not_active Withdrawn
- 2001-01-26 AU AU26997/01A patent/AU2699701A/en not_active Abandoned
- 2001-01-26 UA UA2002086471A patent/UA72789C2/uk unknown
- 2001-01-26 KR KR10-2005-7000487A patent/KR20050009776A/ko not_active Application Discontinuation
- 2001-01-26 OA OA1200200235A patent/OA12174A/en unknown
- 2001-01-26 GE GE4875A patent/GEP20043301B/en unknown
- 2001-01-26 AP APAP/P/2002/002595A patent/AP2002002595A0/en unknown
- 2001-01-26 CZ CZ20022542A patent/CZ20022542A3/cs unknown
- 2001-01-26 PL PL01357094A patent/PL357094A1/xx not_active Application Discontinuation
- 2001-01-26 IL IL15086201A patent/IL150862A0/xx unknown
- 2001-01-26 BR BR0108002-4A patent/BR0108002A/pt not_active IP Right Cessation
- 2001-01-26 EE EEP200200432A patent/EE200200432A/xx unknown
- 2001-01-26 SK SK1088-2002A patent/SK10882002A3/sk not_active Application Discontinuation
- 2001-01-26 KR KR1020027010005A patent/KR20020072304A/ko not_active Application Discontinuation
- 2001-01-26 JP JP2001557855A patent/JP2003522164A/ja not_active Withdrawn
- 2001-01-26 CA CA002399214A patent/CA2399214A1/en not_active Abandoned
- 2001-01-26 EA EA200401099A patent/EA200401099A1/ru unknown
- 2001-01-30 TW TW093137061A patent/TW200804311A/zh unknown
- 2001-01-30 PE PE2001000102A patent/PE20011057A1/es not_active Application Discontinuation
- 2001-01-31 US US09/774,871 patent/US6548671B2/en not_active Expired - Fee Related
- 2001-01-31 GT GT200100021A patent/GT200100021A/es unknown
- 2001-01-31 HN HN2001000021A patent/HN2001000021A/es unknown
- 2001-01-31 UY UY26568A patent/UY26568A1/es not_active Application Discontinuation
- 2001-02-01 AR ARP010100483A patent/AR027349A1/es unknown
- 2001-02-02 SV SV2001000302A patent/SV2002000302A/es not_active Application Discontinuation
- 2001-02-02 TN TNTNSN01021A patent/TNSN01021A1/fr unknown
- 2001-02-05 PA PA20018511401A patent/PA8511401A1/es unknown
-
2002
- 2002-07-11 IS IS6468A patent/IS6468A/is unknown
- 2002-07-15 BG BG106922A patent/BG106922A/xx unknown
- 2002-07-26 HR HRP20020638 patent/HRP20020638A2/hr not_active Application Discontinuation
- 2002-08-01 MA MA26757A patent/MA25653A1/fr unknown
- 2002-08-01 ZA ZA200206140A patent/ZA200206140B/xx unknown
- 2002-08-02 NO NO20023675A patent/NO20023675L/no not_active Application Discontinuation
-
2003
- 2003-02-06 US US10/360,059 patent/US6689886B2/en not_active Expired - Fee Related
- 2003-03-28 HK HK03102236.7A patent/HK1050006A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU745687B2 (en) | Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-alpha binding to its CCR1 receptor | |
| US5719141A (en) | 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amide derivatives | |
| CN107163044B (zh) | 一类具有蛋白酶修饰活性的萘乙二酮化合物及其衍生物 | |
| CN116829571A (zh) | 新型螺旋吡咯烷衍生的抗病毒药物 | |
| WO2003053958A1 (en) | Quinazolinedione derivatives | |
| JPS59118774A (ja) | 置換されたフエニルスルホニルオキシベンズイミダゾ−ルカルバメ−トおよびそれらの製造法 | |
| OA12174A (en) | Heterocyclic amide derivatives. | |
| JPH0667918B2 (ja) | 新規チアゾ−ル誘導体、その製造方法及び強心剤 | |
| JP4348086B2 (ja) | ペプチドデホルミラーゼ阻害剤 | |
| WO2004039375A1 (en) | Methods of using ccr1 antagonists as immunomodulatory agents | |
| WO2003035066A1 (en) | 2-aminoquinolone derivatives for use as impdh inhibitors | |
| EP1498417A1 (en) | Heterocyclic amide derivatives | |
| US20040019217A1 (en) | Dihydoxyhexanoic acid derivatives, their intermediates, and methods of making | |
| US20040049057A1 (en) | Dihydro-furan-2-one derivatives, their intermediates and methods of manufacture | |
| US20230399301A1 (en) | Novel potassium channel inhibitors | |
| MXPA99007887A (es) | Derivados de amida del acido heteroaril-hexanoico, su preparación y su uso como inhibidores selectivos de mip-1alfa que se unen a su receptor ccr1 |